Search

Search Constraints

You searched for: Author/Creator Calvo, Alejandro R.

Search Results

1. A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG‐ACRIN cancer research group (E1908). Issue 3 (9th February 2016)